Acute Myeloid Leukemia | Tumor

CURE’s acute myeloid leukemia page features the latest cancer news and updates on acute myeloid leukemia. Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in acute myeloid leukemia.

FDA Stops Study of Novel Blood Cancer Drug

August 23rd 2022, 9:00pm

Article

The Food and Drug Administration put a full clinical hold on a study of the novel drug FHD-286 in patients with acute myelogenous leukemia and myelodysplastic syndrome after study data showed an increase in a potentially fatal side effect.

First Patient Receives Investigational Cancer Drug-Combination for Relapsed/Refractory Acute Myeloid Leukemia

August 22nd 2022, 7:00pm

Article

Adding the investigational cancer drug lanraplenib to Xospata, if found to be effective, may broaden treatment options for patients with relapsed/refractory FLT3-mutated acute myeloid leukemia.

Trial to Compare Safety and Efficacy of Novel Cell Therapy to Standard of Care in Patients With Rare Blood Cancers

August 3rd 2022, 9:00pm

Article

Enrollment has begun on a phase 3 clinical trial assessing the safety and efficacy of an investigational cell therapy in patients with acute myeloid leukemia, acute lymphocytic leukemia and myelodysplastic syndromes.

Outcomes Are Best When Patients With Cancer Are as Aware of Their Disease as Their Provider, Expert Says

August 2nd 2022, 7:55pm

Video

Patients with cancer are encouraged to learn more about their disease from evidenced-based sources and not “Dr. Google.”

Novel Drug-Chemotherapy Combo After Stem Cell Transplant Associated With ‘Favorable Survival Outcomes’ in Group of Rare Blood Cancers

July 26th 2022, 7:00pm

Article

The findings support future studies of assessing the safety and efficacy of the novel drug-chemotherapy combination as a maintenance strategy following stem cell transplantation across a range of blood cancers, according to the study authors.

Tibsovo Plus Vidaza Is Beneficial for Patients With IDH1-Mutant Acute Myeloid Leukemia

June 4th 2022, 11:50pm

Article

Tibsovo plus Vidaza led to survival benefit for patients with IDH1-mutant acute myeloid leukemia, according to findings from the AGILE clinical trial.

Patient With Leukemia Subtype Undergoes Stem Cell Transplant After Receiving Novel Monotherapy in Early-Phase Trial

April 1st 2022, 7:00pm

Article

Treatment with a novel monotherapy in a patient with relapsed/refractory acute myeloid leukemia was effective enough that a successful, as indicated by a significant reduction in bone marrow blasts, stem cell transplant was performed.

Trial Initiated to Study Protein-Inhibiting Treatment Option for Patients With Acute Leukemia

February 17th 2022, 10:00pm

Article

A trial to examine BMF-219 in patients with relapsed or refractory acute leukemias has begun recruiting patients across multiple U.S. states.

FDA Halts Several Studies Examining Magrolimab-Onureg Combo Across Multiple Cancer Types Due to Serious Side Effects

January 28th 2022, 2:00pm

Article

All clinical trials investigating the combination of magrolimab and the chemotherapy Onureg have been paused due to unforeseen serious side effects experienced by patients with various blood cancers receiving the treatment.

Trial Underway for Potential First Treatment Option of Newly Diagnosed NPM1-Mutant AML

January 12th 2022, 2:30pm

Article

A phase 3 trial has begun to examine entospletinib, a selective inhibitor, as a treatment for patients with newly diagnosed NPM1-mutated acute myeloid leukemia.